NCT05239351View on ClinicalTrials.gov

Evaluating Performance and Safety of the Medical Device Jalucomplex in the Treatment of Facial and Neck Tissue Defects

NACompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

March 7, 2022

Primary Completion Date

July 7, 2022

Study Completion Date

July 7, 2022

Conditions
CicatrixLipodystrophyPlaque
Interventions
DEVICE

Jalucomplex

Device: Jalucomplex Jalucomplex is an injectable intradermal gel containing sodium salts derived from hyaluronic acid.

Trial Locations (1)

300425

SCM Dr. Rosu, Timișoara

All Listed Sponsors
collaborator

Opera CRO, a TIGERMED Group Company

OTHER

lead

I.R.A. Istituto Ricerche Applicate S.p.A.

NETWORK